This is an old revision of this page, as edited by ClueBot NG (talk | contribs) at 01:50, 9 September 2012 (Reverting possible vandalism by 69.249.24.189 to version by Jessyisasmith. False positive? Report it. Thanks, ClueBot NG. (1201865) (Bot)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 01:50, 9 September 2012 by ClueBot NG (talk | contribs) (Reverting possible vandalism by 69.249.24.189 to version by Jessyisasmith. False positive? Report it. Thanks, ClueBot NG. (1201865) (Bot))(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) | This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Kank-A" – news · newspapers · books · scholar · JSTOR (July 2009) (Learn how and when to remove this message) |
Kank-A is a liquid pharmaceutical product marketed by Blistex used primarily to treat canker sores. It is applied directly on the sore and works by numbing the local area (with benzocaine) to prevent discomfort and forming a protective mucous barrier with a compound benzoin tincture that protects the ulcer from further irritation, allowing it to heal more rapidly.
 | This product article is a stub. You can help Misplaced Pages by expanding it. |